Novel Class of Preventive Treatments for Migraine
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Migraine and Headache
The Effects of Puberty and Menstrual Cycle on Migraine in Girls
Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
New Findings on Timing of Migraines After Poor Sleep
Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.
Phenotypes May Aid Diagnosis and Treatment of Pediatric Headache
Researchers posit that adult studies on headache can help to create a multidisciplinary treatment plan.
The Association Between Different Subtypes of Major Depressive Disorder and Migraine
Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.
Reviewing Interventional Treatments for Chronic Headache
Interventional pain modalities provide alternative analgesia in patients who are intolerant of pharmacologic agents, have comorbidities that require multiple medications, or have pain refractory to oral medications.
Personality Trait Differences Shown Between Patients With Migraine, Medication-Overuse Headache
Researchers found data that showed women who are introverts have a propensity toward medication-overuse headache, rather than migraines.
Smartphone-Based Progressive Muscle Relaxation May Reduce Monthly Headache Days in Migraine
The use of a smartphone-based progressive muscle relaxation was found to be associated with a reduction in monthly headache days and depression scores in patients with migraine.
Zonisamide Effective for Cluster Headache Prophylaxis
Zonisamide, a sulfonamide anticonvulsant, demonstrated promising efficacy for the prophylactic treatment of chronic and episodic cluster headache disorders.
Emgality Approved to Treat Episodic Cluster Headache in Adults
The FDA has approved Emgality (galcanezumab-gnlm; Lilly) for injection for the treatment of episodic cluster headache in adults.
-
Loading...
-
Loading...
Next post in Uncategorized
